Clinical Trial

A Clinical Study to Evaluate CUD005 Injection in Patients with Liver Cirrhosis

Enrolling by Invitation Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated November 4, 2024 (before its estimated October 2025 completion). Its status may not reflect the trial's current state.
Summary
A single-arm, open-label, dose-escalation phase I clinical trial to evaluate the safety, tolerability, and preliminary efficacy of CUD005 injection in patients with liver cirrhosis
Trial Details
NCT Number NCT06671275
Lead Sponsor Anhui Provincial Hospital
Conditions Cirrhosis Liver
Enrollment 9 participants
Start Date 2024-06-21
Primary Completion 2025-10 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-11-04